Zonampanel anhydrous

DB20448InvestigationalSmall molecule

Zonampanel anhydrous is a small molecule drug. Zonampanel anhydrous is under investigation in clinical trial NCT00044070 (A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute... Zonampanel anhydrous has a monoisotopic molecular weight of 331.06 Da.

Chemical structure of Zonampanel anhydrous
Formula / weight
C13H9N5O6 · 331.244 g/mol (avg)
Also known as
Zonampanel
Code names
YM-872 ANHYDROUS

Resolves to

Compound
UNII9X33544ILSCAS210245-80-0ChEMBLCHEMBL119625ChEBI748492PubChem148200
Structure
InChIKeySPXYHZRWPRQLNS-UHFFFAOYSA-NSMILESOC(=O)CN1C(=O)C(=O)NC2=CC(=C(C=C12)N1C=CN=C1)[N+]([O-])=O
Targets
P42261GRIA1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Zonampanel anhydrous, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In